Santhera and ReveraGen to Present Phase 2a/2b Efficacy and New Safety Data with Vamorolone at Forthcoming Conferences
Pratteln, Switzerland, and Rockville, MD, USA, September 23, 2021 – Santhera Pharmaceuticals (SIX: SANN) and ReveraGen BioPharma, Inc (US: private) announce presentations of the positive topline results from the...
Read more